Tm Bioscience Licenses P450 PGx Marker From Epidauros Biotechnologie | GenomeWeb

NEW YORK, March 14 (GenomeWeb News) - Tm Bioscience said today that it has taken a co-exclusive commercial license to Epidauros Biotechnologie's patents on a specific biomarker related to the P450-CYP2D6 gene.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.